Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fidaxomicin Prophylaxis for C. difficile Infection
NCT01552668Phase 4Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fidaxomicin in Clostridioides difficile infection (CDI), sponsored by Washington University School of Medicine. Planned start Sep 2012; status: withdrawn.
02
Drugs
fidaxomicin
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT01552668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552668.